miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways

MicroRNAs (miRNAs) are attractive therapeutic targets for various therapy-resistant tumors. However, the association between miRNA and BRAF inhibitor resistance in melanoma remains to be elucidated. We used microarray analysis to comprehensively study the miRNA expression profiling of vemurafenib re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaoyan, Li, Jun, Sun, Yanhong, Zhang, Yi, Dong, Liyun, Shen, Chen, Yang, Liu, Yang, Ming, Li, Yan, Shen, Guanxin, Tu, Yating, Tao, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288205/
https://www.ncbi.nlm.nih.gov/pubmed/27448964
http://dx.doi.org/10.18632/oncotarget.10669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288205/
https://www.ncbi.nlm.nih.gov/pubmed/27448964
http://dx.doi.org/10.18632/oncotarget.10669

Ejemplares similares